ACA β€” ARCOSA INC

Ownership history in ROYCE & ASSOCIATES LP  Β·  29 quarters on record

This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in ARCOSA INC (ACA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.33% (2025 Q4)
πŸ“Š Avg. % of fund
0.83%
πŸ“… First filed
2018 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
29

Position Intelligence

ROYCE & ASSOCIATES LP Γ— ACA AI Analytics

πŸ“ˆ ROYCE & ASSOCIATES LP outperformed the S&P 500 by +6.0% annually on this ACA position. Timing score: 71% (20/28 decisions correct). Average cost basis: $38.37. Maximum drawdown during holding period: –28.3%.

πŸ“ˆ Position Alpha vs SPY
+6.0%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 6.0% per year on this position.
28 quarters analyzed

⏱️ Timing Score
71%

🎯 Smart timing β€” consistently buying dips and trimming near peaks.
20 of 28 add/trim decisions correct

πŸ’° Entry Quality
$38.37
+177.0% vs current ($106.27)

Best entry: $26.97 (2018 Q4)  Β·  Worst: $93.62 (2025 Q3)

πŸ›‘οΈ Drawdown Resilience
–28.3%
max drawdown while held

πŸ’ͺ Held through 2 major drawdowns (>20%).

πŸ’ͺ Fund Conviction
52%
buy-side decisions

15 adds Β· 14 trims. Bought during 5 of 9 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
↑ Growing
last 4–5 quarters trend

πŸ“ˆ ROYCE & ASSOCIATES LP has been actively increasing its ACA allocation β€” a bullish signal from insiders.
Currently 1.33% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ACA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,234,455 -32,636 -2.6% 1.33% $131.2M $106.27
2025 Q3 ADDED 1,267,091 +4,652 +0.4% 1.18% $118.7M $93.62
2025 Q2 ADDED 1,262,439 +8,351 +0.7% 1.12% $109.5M $86.58
2025 Q1 ADDED 1,254,088 +14,839 +1.2% 1.05% $96.7M $76.95
2024 Q4 REDUCED 1,239,249 -128,525 -9.4% 1.11% $119.9M $96.48
2024 Q3 REDUCED 1,367,774 -61,136 -4.3% 1.18% $129.6M $94.45
2024 Q2 ADDED 1,428,910 +1,643 +0.1% 1.11% $119.2M $83.09
2024 Q1 REDUCED 1,427,267 -31,824 -2.2% 1.09% $122.5M $85.48
2023 Q4 ADDED 1,459,091 +56,055 +4.0% 1.11% $120.6M $82.22
2023 Q3 REDUCED 1,403,036 -21,310 -1.5% 1.03% $100.9M $71.49
19 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ACA

As of 2025 Q4 β€” sorted by position size

Orchard Capital Management, LLC 3Y 3.15% AYAL Capital Advisors Ltd 2.48% PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 3Y 7Y 2.24% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.09% OBERWEIS ASSET MANAGEMENT INC/ 3Y 7Y 0.86% SILVERCREST ASSET MANAGEMENT GROUP LLC 3Y 7Y 0.8% Consolidated Investment Group LLC 3Y 7Y 0.67% HARBOR CAPITAL ADVISORS, INC. 3Y 0.62% TCTC Holdings, LLC 3Y 7Y 0.58% Jackson Creek Investment Advisors LLC 3Y 0.54%
← Back to ROYCE & ASSOCIATES LP Holdings